Hardik Shah
2026.07.20 11:05

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: Bristol Myers Squibb Expands AI Infrastructure With Nvidia DGX Vera Rubin - $Bristol Myers Squibb(BMY.US) $NVIDIA(NVDA.US)

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค ๐๐ซ๐ข๐ฌ๐ญ๐จ๐ฅ ๐Œ๐ฒ๐ž๐ซ๐ฌ ๐’๐ช๐ฎ๐ข๐›๐› will deploy an ๐๐ฏ๐ข๐๐ข๐š ๐ƒ๐†๐— ๐’๐ฎ๐ฉ๐ž๐ซ๐๐Ž๐ƒ.

โžค Infrastructure includes ๐ƒ๐†๐— ๐•๐ž๐ซ๐š ๐‘๐ฎ๐›๐ข๐ง ๐๐•๐‹๐Ÿ•๐Ÿ systems.

โžค Vera Rubin delivers up to ๐ˆ๐ŸŽ๐ฑ greater performance per megawatt.

โžค AI infrastructure will support research across ๐จ๐ง๐œ๐จ๐ฅ๐จ๐ ๐ฒ, ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ฅ๐จ๐ ๐ฒ, and neuroscience.

โžค BMS will develop ๐€๐ˆ ๐Ÿ๐จ๐ฎ๐ง๐๐š๐ญ๐ข๐จ๐ง ๐ฆ๐จ๐๐ž๐ฅ๐ฌ using proprietary data.

โžค Platform will power ๐š๐ ๐ž๐ง๐ญ๐ข๐œ ๐€๐ˆ workflows for drug discovery.

โžค BMS will use its ๐๐ซ๐ž๐๐ข๐œ๐ญ ๐…๐ข๐ซ๐ฌ๐ญ approach to guide experiments.

โžค Agreement includes access to ๐๐ฏ๐ข๐๐ข๐š ๐๐ข๐จ๐๐ž๐Œ๐จ and Agent Toolkit.

โžค Financial terms of the collaboration were ๐ง๐จ๐ญ ๐๐ข๐ฌ๐œ๐ฅ๐จ๐ฌ๐ž๐.

๐Ÿ‘‰ ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ ๐’๐ญ๐š๐ญ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ:

๐†๐ซ๐ž๐  ๐Œ๐ž๐ฒ๐ž๐ซ๐ฌ, Chief Digital and Technology Officer at Bristol Myers Squibb:

"BMS has made a deliberate bet on AI, and we are beginning to see it pay off in our pipeline and operations. Expanding our compute capabilities with Nvidia gives our researchers and teams across the business the scale they need to keep BMS at the leading edge of what AI can do for drug discovery and development."

๐‘๐จ๐›๐ž๐ซ๐ญ ๐๐ฅ๐ž๐ง๐ ๐ž, Executive Vice President and Chief Research Officer at Bristol Myers Squibb:

"The goal isn't speed for its own sake; it's raising the probability that each program we advance is the right one."

๐‘๐จ๐ซ๐ฒ ๐Š๐ž๐ฅ๐ฅ๐ž๐ก๐ž๐ซ, Senior Director of Business Development, Healthcare and Life Sciences at Nvidia:

"The tools will allow BMS to convert its scientific data into proprietary intelligence to support molecule design and hypothesis evaluation."

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

ยฉ 2026 Longbridge๏ฝœDisclaimer